Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease (INTREPID)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Boston Scientific Corporation
Sponsor:
Information provided by (Responsible Party):
Boston Scientific Corporation
ClinicalTrials.gov Identifier:
NCT01839396
First received: April 22, 2013
Last updated: November 15, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2021
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)